BUY IPCA Laboratories Limited — Sumeet Bagadia, Choice Broking
bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))6 Aug 2026via LiveMint Buy-or-Sell (topic)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Is It Worth Considering Ipca Laboratories Limited (NSE:IPCALAB) For Its Upcoming Dividend?
NewsGoogle News·3 Aug · 1w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·10 Jul · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
More from Sumeet Bagadia, Choice Broking
- BUY Sun Pharmaceutical Industries23 Oct 2026 · Same day · target ₹1,790 · Expired
- BUY Coforge22 Oct 2026 · Same day · target ₹1,980 · Target hit
- BUY NHPC21 Oct 2026 · ~2 weeks · target ₹75 · SL hit
- BUY Titan Company20 Oct 2026 · ~3 months · target ₹4,860 · Active
- BUY The Jammu & Kashmir Bank19 Oct 2026 · ~2 weeks · target ₹146 · SL hit

